# Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis

> **NCT07489521** · PHASE4 · RECRUITING · sponsor: **Cappagh National Orthopaedic Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Osteo Arthritis Knee
- Osteoarthritis
- Intraarticular Injection

## Interventions

- **DEVICE:** Arthrosamid® 2.5% iPAAG injectable implant
- **DRUG:** Steroid Drug

## Key facts

- **NCT ID:** NCT07489521
- **Lead sponsor:** Cappagh National Orthopaedic Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-29
- **Primary completion:** 2027-09
- **Final completion:** 2027-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07489521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07489521, "Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07489521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*